Physician_Profile_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Record_ID,Name_of_Associated_Covered_Drug_or_Biological1,Name_of_Associated_Covered_Drug_or_Biological2,Name_of_Study,Research_Information_Link,Context_of_Research
163314,"Integra LifeSciences Corporation",NJ,100000010950,23250.00,05/14/2014,"Cash or cash equivalent",201924458,"","","Multi-Center prospective study with Endoscopic Cubital Tunnel Release","","Multi-Center prospective study with Endoscopic Cubital Tunnel Release"
163314,"Integra LifeSciences Corporation",NJ,100000010950,10000.00,02/03/2014,"Cash or cash equivalent",201924442,"","","A multi-center, randomized, prospective study with endoscopic cubital tunnel release","","Retrospective, long-term follow up to assess resolution of symptoms, satisfaction, recurrence rates, complication rate, return to work"
